Structural Formula (Labetalol HCl In Sodium Chloride Injection And Lab 1)
Labetalol Hcl In Sodium Chloride Injection
Product Images NDC 0143-9363
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Labetalol Hcl In Sodium Chloride (NDC 0143-9363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Labetalol HCl In Sodium Chloride Injection And Lab 10
Labetalol HCl In Sodium Chloride Injection And Lab 11
This is a description of Labetalol Hydrochloride in 5% Dextrose Injection, with each mL containing 1 mg of labetalol HCI, for intravenous infusion. It comes sterilized and nonpyrogenic in a single-dose flexible container that shouldn't be removed from the overwrap until ready to use. If any leaks are found, the unit should be discarded as sterility may be impaired. It's manufactured by HIKMA FARMACEUTICA in Portugal and distributed by Hikma Pharmaceuticals USA Inc. The recommended dosage is specified in the Prescribing Information, and it should be stored at room temperature and out of direct light.*
Labetalol HCl In Sodium Chloride Injection And Lab 12
This text appears to be related to an inventory or stock list. It includes an expiration date of 12/2099, a lot number of 18120001, and a quantity of 0000. However, since the text is incomplete and lacks context, it is difficult to determine what specific item or product this information pertains to.*
Bag 9363 (Labetalol HCl In Sodium Chloride Injection And Lab 2)
Bag 9364 (Labetalol HCl In Sodium Chloride Injection And Lab 3)
Bag 9365 (Labetalol HCl In Sodium Chloride Injection And Lab 4)
This is a medication with NDC number 0143-9363-01 which is available only by prescription. It comes in a single-dose flexible container of 100 mL that is sterile and nonpyrogenic. The medication is Labetalol Hydrochloride in 0.72% Sodium Chloride Injection used for intravenous infusion and is ready to use. Each container contains 1 mg of fabstalol K0, 7.2 g of so0am cioide, 9 g of ntyorous dextoss, and 002 mg of edefate discdium and has a pH range of 3.5-10.45. Recommended dosage and information on prescribing can be found in the prescribing information. The medication should be stored between 20° and 25°C (68° and 77°F) and protected from light. Unused portions should be discarded, and the flexible container should not be used if it shows signs of damage. The container should also not be used in series connections.*
Bag 9366 (Labetalol HCl In Sodium Chloride Injection And Lab 5)
This is a description of Labetalol Hydrochloride in 0.72% Sodium Chloride Injection, a sterile, non-pyrogenic, and single-dose flexible container, with 100mg per 100mL (1mg/mL). It is intended for intravenous infusion and is ready to use. Each mL contains 1 mg of Labetalol HCI, 7.2 mg sodium chloride, 9mg anhydrous dextrose, 0.02 mg of edetat disodium, and other necessary ingredients. The pH range of the solution is between 3.5-4.5. It is necessary to check for minute leaks by squeezing the container firmly. Not to use if overwrap has been previously opened, damaged or in case a leak is found. Recommended Dosage is given in Prescribing Information, and it is stored between 20° to 25 (68° to 77°F). It is distributed by Hima Pharmaceuticals USA Inc. and manufactured by HIKMA FARMACEUTICA (PORTUGAL), SA.*
Bag Serizliation Image (Labetalol HCl In Sodium Chloride Injection And Lab 6)
The text describes a medication called Labetalol Hydrochloride in Sodium Chloride Injection, which is meant for prescription use only. The medication comes in a 200 mL single-dose flexible container with a concentration of 1 mg/mL. The solution contains labetalol hydrochloride, sodium chloride, dextrose, edetate disodium, citric acid monohydrate, and sodium hydroxide. The pH range of the solution is 3.5 to 10.5. The recommended dosage is available in the prescribing information. The medication should be stored between 20 to 25°C (66 to 77°F), protected from light and is preservative-free. The user should discard unused portions and not use if the container is damaged or leaking. The manufacturer is HIKMA FARMACEUTICA (PORTUGAL), and Hikma Pharmaceuticals USA Inc. distribute it.*
Labetalol HCl In Sodium Chloride Injection And Lab 7
The text describes a medication called Labetalol Hydrochloride that is administered via intravenous infusion. It is available in a ready-to-use single-dose flexible container and contains 200 mg per 200 mL. The recommended dosage should be found in the Prescribing Information. It must be stored at controlled room temperature, protected from light and not used via series connections. If there are leaks, the unit should be discarded as sterility may be impaired. The medication is manufactured by HKMA Farmageltica and distributed by Hiki Pharmaceuticals USA Inc.*
Labetalol HCl In Sodium Chloride Injection And Lab 8
This is a prescription medication with the National Drug Code 0143-9365-01. Each 300 mL container contains Labetalol Hydrochloride in 0.72% Sodium Chloride Injection for intravenous infusion. The ready-to-use sterile and non-pyrogenic solution contains 1 mg/mL of labetalol hydrochloride, along with sodium chiorde, anhydrous dextrose, edetate cisodium, acid monohydrate, and sodium hycrovide to bring the solution to a pH range of 3.5 to 4.5. It is recommended to see prescribing information for dosage, store at 20° to 25° C, and protect it from light. If the flexible container leaks or shows damage, one should discard the unused portion. The manufacturer is Hikma Farmageutica (Portugal) with the distributor being Hikma Pharmaceuticals USA Inc. The product cannot be used in series connections.*
Labetalol HCl In Sodium Chloride Injection And Lab 9
NDC 0143-9365-01 is a single-dose flexible container of Labetalol Hydrochloride in 0.72% Sodium Chloride Injection for intravenous infusion. Each mL contains 1 mg of labetalol HCI, 7.2 mg sodium chloride, 9 mg of anhydrous dextrose, 0.02 mg of edetate disodium. The solution has citric acid monohydrate and sodium hydroxide, as necessary, to keep the pH within the range of 3.5 to 4.5. It is recommended to not use in series connections; discard unused portion; and not use if overwrap has been previously opened or damaged. It is manufactured by HIMA FARMACEUTICA (PORTUGAL), S.A. and distributed by Hikma Pharmaceuticals USA Inc. The recommended dosage is indicated in the prescribing information. It is sterile, nonpyrogenic, preservative-free, and must be stored at 20° to 25°C (68° to 77°F), protected from light.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
